Need help finding what you are looking for?
Contact Us
PUBLISHER: GlobalData | PRODUCT CODE: 1780399
PUBLISHER: GlobalData | PRODUCT CODE: 1780399
North America Cardiac Disease Market Outlook to 2033 - Cardiac Marker Tests
PUBLISHED:
PAGES: 73 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
GlobalData's "North America Cardiac Disease Market Outlook to 2033" is a comprehensive databook report, covering key market data on the North America Cardiac Disease market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Cardiac Marker Tests
The North America Cardiac Disease Market report provides key information and data on -
- Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
- 2024 company share data for Cardiac Disease Market.
- Global corporate-level profiles of key companies operating within the North America Cardiac Disease Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.
Scope
North America Cardiac Disease is segmented as follows -
- Cardiac Marker Tests
Reasons to Buy
The North America Cardiac Disease Market report helps you to develop -
- Business strategies by identifying the key market segments poised for strong growth in the future.
- Market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
Product Code: GDME20406CRDB
Table of Contents
1 Table of Contents
- 1.1 List of Tables
- 1.2 List of Figures
2 Introduction
- 2.1 What Is This Report About?
- 2.2 Cardiac Disease Market Segmentation
- 2.3 Definitions of Markets Covered in the Report
3 Cardiac Disease Market, North America
- 3.1 Cardiac Disease Market, North America, Revenue ($m), 2018-2033
- 3.2 Cardiac Disease Market, North America, Revenue ($m), 2018-2033
- 3.3 Cardiac Disease Market, North America, Volume (Units), 2018-2033
- 3.4 Cardiac Disease Market, North America, Volume (Units), 2018-2033
- 3.5 Cardiac Disease Market, North America, Company Share by Revenue ($m), 2024
4 Cardiac Disease Market, Canada
- 4.1 Cardiac Disease Market, Canada, Revenue ($m), 2018-2033
- 4.1.1 Cardiac Marker Tests Market, Canada, Revenue ($m), by Segment, 2018-2033
- 4.2 Cardiac Disease Market, Canada, Volume (Units), 2018-2033
- 4.2.1 Cardiac Marker Tests Market, Canada, Volume (Units), by Segment, 2018-2033
- 4.3 Cardiac Disease Market, Canada, Average Price ($), 2018-2033
- 4.4 Cardiac Disease Market, Canada, Company Share by Revenue ($m), 2024
5 Cardiac Disease Market, United States
- 5.1 Cardiac Disease Market, United States, Revenue ($m), 2018-2033
- 5.1.1 Cardiac Marker Tests Market, United States, Revenue ($m), by Segment, 2018-2033
- 5.2 Cardiac Disease Market, United States, Volume (Units), 2018-2033
- 5.2.1 Cardiac Marker Tests Market, United States, Volume (Units), by Segment, 2018-2033
- 5.3 Cardiac Disease Market, United States, Average Price ($), 2018-2033
- 5.4 Cardiac Disease Market, United States, Company Share by Revenue ($m), 2024
6 Cardiac Disease Market, Mexico
- 6.1 Cardiac Disease Market, Mexico, Revenue ($m), 2018-2033
- 6.1.1 Cardiac Marker Tests Market, Mexico, Revenue ($m), by Segment, 2018-2033
- 6.2 Cardiac Disease Market, Mexico, Volume (Units), 2018-2033
- 6.2.1 Cardiac Marker Tests Market, Mexico, Volume (Units), by Segment, 2018-2033
- 6.3 Cardiac Disease Market, Mexico, Average Price ($), 2018-2033
- 6.4 Cardiac Disease Market, Mexico, Company Share by Revenue ($m), 2024
7 Overview of Key Companies in North America Cardiac Disease Market
- 7.1 F. Hoffmann-La Roche Ltd
- 7.1.1 Company Overview
- 7.2 Abbott Laboratories
- 7.2.1 Company Overview
- 7.3 Beckman Coulter Inc
- 7.3.1 Company Overview
- 7.4 Quidel Corp
- 7.4.1 Company Overview
- 7.5 Siemens Healthineers AG
- 7.5.1 Company Overview
- 7.6 bioMerieux SA
- 7.6.1 Company Overview
8 Cardiac Disease Market Pipeline Products
9 Recent Developments
- 9.1 Corporate Communications
- 9.1.1 Mar 03, 2025: Pulnovo secures $100m to advance clinical trials and business expansion
- 9.2 Government and Public Interest
- 9.2.1 Feb 11, 2025: New Implant May Help Patients Regenerate Their Own Heart Valves
- 9.3 Other Significant Developments
- 9.3.1 Oct 09, 2024: Heart Health for All: How We Can Improve Access to Cardiac Care around the Globe
- 9.3.2 Oct 08, 2024: Amwell Expands Clinical Programs Portfolio to Include Hello Heart Cardiovascular Health Risk Management Solution
- 9.4 Product News
- 9.4.1 Jun 09, 2025: Microtech Announces the First U.S. Atrial Microsensor Implantations as Part of Its FIH Study
- 9.4.2 Apr 28, 2025: Simple Blood Test Could Better Predict Heart Disease Risk
- 9.4.3 Feb 28, 2025: Allegheny General Hospital First in Western PA to Participate in Clinical Trial Using Artificial Intelligence to Detect Deep Vein Thrombosis in Cardiac Patients
- 9.4.4 Jan 28, 2025: New Data Finds 31% of Working Americans and Their Families Have a Cardiac Disorder
- 9.4.5 Jan 09, 2025: Peerbridge Health Unveils Cor-Insight Trial To Validate Revolutionary Ai-Enabled Cardiac and Cardiopulmonary Diagnostics & Monitoring
- 9.4.6 Dec 16, 2024: Streamlining Analysis of Ion Channel in Vitro Assays Data to Support Clinical Cardiac Safety Decision-Making
- 9.4.7 Sep 30, 2024: New Wearable Laser Device Monitors Brain Blood Flow to Gauge Stroke Risk
- 9.4.8 Aug 20, 2024: Brigham Researchers Use AI Tools to Uncover Connections Between Radiotherapy for Lung Cancer and Heart Complications
- 9.4.9 Aug 19, 2024: American Chemical Society : Improving Access to Heart-Failure Screening with Saliva
- 9.4.10 Jun 27, 2024: SoftWave TRT Affiliate Study Featured in Prominent Medical Journal
- 9.5 Strategy And Business Planning
- 9.5.1 Dec 18, 2024: Medera's Novoheart Enters Into Transformative Partnership With Curi Bio
- 9.5.2 Jul 29, 2024: TELUS and University of Ottawa Heart Institute partner to boost emergency cardiac care efficiency with smartphone app
- 9.5.3 Jun 27, 2024: Elucid Moves into New Headquarters in Preparation for Commercial Launch
10 Appendix
- 10.1 Research Methodology
- 10.1.1 Coverage
- 10.1.2 Secondary Research
- 10.1.3 Primary Research
- 10.1.4 Market Modeling and Forecasting
- 10.1.5 Company Share Analysis
- 10.1.6 Benchmarking
- 10.2 GlobalData Consulting
- 10.3 Contact Us
- 10.4 Disclaimer
Product Code: GDME20406CRDB
List of Table
List of Tables
- Table 1: Cardiac Disease Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2018-2033
- Table 2: Cardiac Disease Market, North America, Revenue ($m), USD Constant, 2018-2033
- Table 3: Cardiac Disease Market, North America, Volume (Units), 2018-2033
- Table 4: Cardiac Disease Market, North America, Volume (Units), 2018-2033
- Table 5: Cardiac Disease Market, North America, Company Share by Revenue ($m), 2024
- Table 6: Cardiac Disease Market, Canada, Revenue ($m), USD Constant, 2018-2033
- Table 7: Cardiac Marker Tests Market, Canada, Revenue ($m), USD Constant, 2018-2033
- Table 8: Cardiac Disease Market, Canada, Volume (Units), 2018-2033
- Table 9: Cardiac Marker Tests Market, Canada, Volume (Units), 2018-2033
- Table 10: Cardiac Disease Market, Canada, Average Price ($), 2018-2033
- Table 11: Cardiac Disease Market, Canada, Company Share by Revenue ($m), 2024
- Table 12: Cardiac Disease Market, United States, Revenue ($m), USD Constant, 2018-2033
- Table 13: Cardiac Marker Tests Market, United States, Revenue ($m), USD Constant, 2018-2033
- Table 14: Cardiac Disease Market, United States, Volume (Units), 2018-2033
- Table 15: Cardiac Marker Tests Market, United States, Volume (Units), 2018-2033
- Table 16: Cardiac Disease Market, United States, Average Price ($), 2018-2033
- Table 17: Cardiac Disease Market, United States, Company Share by Revenue ($m), 2024
- Table 18: Cardiac Disease Market, Mexico, Revenue ($m), USD Constant, 2018-2033
- Table 19: Cardiac Marker Tests Market, Mexico, Revenue ($m), USD Constant, 2018-2033
- Table 20: Cardiac Disease Market, Mexico, Volume (Units), 2018-2033
- Table 21: Cardiac Marker Tests Market, Mexico, Volume (Units), 2018-2033
- Table 22: Cardiac Disease Market, Mexico, Average Price ($), 2018-2033
- Table 23: Cardiac Disease Market, Mexico, Company Share by Revenue ($m), 2024
- Table 27: Cardiac Disease Market Pipeline Products
- Table 13: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country
List of Figure
List of Figures
- Figure 1: Cardiac Disease Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2018-2033
- Figure 2: Cardiac Disease Market, North America, Revenue ($m), USD Constant, 2018-2033
- Figure 3: Cardiac Disease Market, North America, Volume (Units), 2018-2033
- Figure 4: Cardiac Disease Market, North America, Volume (Units), 2018-2033
- Figure 5: Cardiac Disease Market, North America, Company Share (%), 2024
- Figure 6: Cardiac Disease Market, Canada, Revenue ($m), USD Constant, 2018-2033
- Figure 7: Cardiac Marker Tests Market, Canada, Revenue ($m), USD Constant, 2018-2033
- Figure 8: Cardiac Disease Market, Canada, Volume (Units), 2018-2033
- Figure 9: Cardiac Marker Tests Market, Canada, Volume (Units), 2018-2033
- Figure 10: Cardiac Disease Market, Canada, Company Share (%), 2024
- Figure 11: Cardiac Disease Market, United States, Revenue ($m), USD Constant, 2018-2033
- Figure 12: Cardiac Marker Tests Market, United States, Revenue ($m), USD Constant, 2018-2033
- Figure 13: Cardiac Disease Market, United States, Volume (Units), 2018-2033
- Figure 14: Cardiac Marker Tests Market, United States, Volume (Units), 2018-2033
- Figure 15: Cardiac Disease Market, United States, Company Share (%), 2024
- Figure 16: Cardiac Disease Market, Mexico, Revenue ($m), USD Constant, 2018-2033
- Figure 17: Cardiac Marker Tests Market, Mexico, Revenue ($m), USD Constant, 2018-2033
- Figure 18: Cardiac Disease Market, Mexico, Volume (Units), 2018-2033
- Figure 19: Cardiac Marker Tests Market, Mexico, Volume (Units), 2018-2033
- Figure 20: Cardiac Disease Market, Mexico, Company Share (%), 2024
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.